Please wait a minute...
科技与出版  2026, Vol. 45 Issue (8): 131-145    
学术探索
我国医学期刊实施国际研究报告规范的现状分析:基于卓越行动计划二期项目入选医学期刊的调查
胡晓静1,王尔亮2,丁媛媛1,张苹1
1. 上海市卫生和健康发展研究中心(上海市医学科学技术情报研究所), 200031, 上海
2. 上海交通大学医学院附属瑞金医院编辑部, 200025, 上海
Implementation of International Reporting Guidelines in Chinese Medical Journals: A Survey of Journals Selected for Phase Ⅱ of the Action Plan for Excellent STM Journals
HU Xiaojing1,WANG Erliang2,DING Yuanyuan1,ZHANG Ping1
1. Shanghai Health Development Research Center (Shanghai Medical Information Center), 200031, Shanghai, China
2. Editorial Office, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 200025, Shanghai, China
全文: HTML    PDF(1790 KB)  
输出: BibTeX | EndNote (RIS)      
摘要: 

该研究通过调研分析入选中国科技期刊卓越行动计划二期项目的医学期刊,探讨我国医学期刊实施国际研究报告规范的现状及存在的问题,提出优化策略,为我国医学期刊实施研究报告规范提供参考。研究通过网络调研、文献检索等方法,分析EQUATOR协作网中15项主要医学研究报告规范的特点和发表情况;入选卓越行动计划二期项目医学期刊稿约及期刊网站采用研究报告规范的情况,以及发表的随机试验、系统评价和Meta分析、临床实践指南和共识文献执行研究报告规范的情况。研究结果表明,我国尚无期刊发表EQUATOR协作网的15项主要研究报告规范原文。卓越行动计划二期项目入选医学期刊中,36种(83.72%)英文期刊和27种(57.45%)中文期刊在其出版平台中建议或要求按照研究报告规范撰写相关报告。17种(39.53%)英文期刊和14种(29.79%)中文期刊建议或要求使用的研究报告规范数量超过3种。卓越二期项目入选英文医学期刊对随机试验及系统评价和Meta分析相关指标的报告较为规范,对指南和共识相关指标的报告规范性有待提升;中文医学期刊对系统评价和Meta分析及指南和共识的部分相关指标报告较为规范,对随机试验相关指标的报告规范执行情况较差,3类研究的注册率均较低。我国医学期刊应重视对研究报告规范的发表工作,逐步加强对研究报告规范的采用和落地实施,可进一步参考国内外期刊典型案例,借助集群化办刊的力量,完善期刊政策,深入实施研究报告规范。

关键词 : 医学期刊,  学术期刊,  研究报告规范,  出版平台,  稿约,  期刊集群    
Abstract:

Objective: By analyzing the medical journals selected for Phase Ⅱ of the Action Plan for Excellent STM Journals, this study aims to examine the current status and problems in the implementation of international reporting guidelines in Chinese medical journals, propose optimization strategies, and provide a basis for strengthening their implementation in Chinese medical journals. Methods: Using web-based research and literature searches, the study analyzed the characteristics and publication status of 15 major reporting guidelines in the EQUATOR Network, the adoption of these guidelines in the instructions for authors and on the websites of medical journals selected for Phase Ⅱ of the Action Plan for Excellent STM Journals, and compliance with reporting guidelines in published randomized trials, systematic reviews and meta-analyses, and clinical practice guidelines and consensus documents. Results: No Chinese journal published the original texts of the 15 major reporting guidelines in the EQUATOR Network. Among 43 English-language journals and 47 Chinese-language journals selected for Phase Ⅱ of the Action Plan for Excellent STM Journals, 36 (83.72%) English-language journals and 27 (57.45%) Chinese-language journals recommended or required adherence to reporting guidelines when preparing relevant research articles on their publishing platforms. Additionally, 17 (39.53%) English-language journals and 14 (29.79%) Chinese-language journals recommended or required the use of more than three reporting guidelines. For journals selected for Phase Ⅱ of the Action Plan for Excellent STM Journals, 19 English-language medical journals and 35 Chinese-language medical journals published 118 and 404 randomized trials, respectively; 25 English-language medical journals and 22 Chinese-language medical journals published 91 and 145 systematic reviews and meta-analyses, respectively; 16 English-language medical journals and 40 Chinese-language medical journals published 57 and 538 clinical practice guidelines and consensus statements, respectively. The English-language medical journals selected for Phase Ⅱ of the Action Plan for Excellent STM Journals demonstrated relatively good compliance with indicators specified in reporting guidelines for randomized trials and systematic reviews and meta-analyses, but compliance with reporting guidelines for clinical practice guidelines and consensus statements requires further improvement; Chinese-language medical journals showed relatively good reporting compliance for some indicators related to reporting guidelines of systematic reviews and meta-analyses and clinical practice guidelines and consensus, but exhibited poor adherence in implementing reporting guidelines for randomized trials, and the registration rates for all three types of studies were low. Conclusion: Chinese medical journals should attach importance to the publication of reporting guidelines, and gradually strengthen the adoption and implementation of these guidelines. By further drawing on exemplary cases from both domestic and international journals, and leveraging the advantages of clustered journal management, Chinese medical journals can refine journal policies and deepen the implementation of reporting guidelines, thereby promoting the sustained improvement of research report quality.

Key words: medical journals    academic journals    reporting guidelines    publishing platforms    instructions for authors    journal clusters
出版日期: 2026-09-08
基金资助:上海市2025年度高水平机构建设运行计划“软科学研究”项目(25692105300)

引用本文:

胡晓静,王尔亮,丁媛媛,张苹. 我国医学期刊实施国际研究报告规范的现状分析:基于卓越行动计划二期项目入选医学期刊的调查[J]. 科技与出版, 2026, 45(8): 131-145.
HU Xiaojing,WANG Erliang,DING Yuanyuan,ZHANG Ping. Implementation of International Reporting Guidelines in Chinese Medical Journals: A Survey of Journals Selected for Phase Ⅱ of the Action Plan for Excellent STM Journals. Science-Technology & Publication, 2026, 45(8): 131-145.

链接本文:

http://kjycb.tsinghuajournals.com/CN/      或      http://kjycb.tsinghuajournals.com/CN/Y2026/V45/I8/131

表 1  EQUATOR协作网首页推荐的主要研究类型相关研究报告规范及其发表情况
表 2  入选中国科技期刊卓越行动计划二期项目医学期刊对研究报告规范的采用情况
表 3  入选卓越二期项目医学期刊2025年3种研究类型报告规范执行情况
表 4  2025年随机试验文献2个指标报告占比均≥50%的入选卓越二期项目医学期刊
表 5  2025年系统评价和Meta分析文献3个指标报告占比均≥50%的入选卓越二期项目医学期刊
表 6  2025年指南和共识文献2个指标报告占比均≥50%的入选卓越二期项目医学期刊
1 Plint A C , Moher D , Morrison A , et al. Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review[J]. Medical Journal of Australia, 2006, 185 (5): 263- 267.
2 Turner L , Shamseer L , Altman D G , et al. Does use of the CONSORT Statement impact the completeness of reporting of randomised controlled trials published in medical journals? A Cochrane review[J]. Systematic Reviews, 2012, 1 (1): 60.
3 Sewell K A , Schellinger J , Bloss J E . Effect of PRISMA 2009 on reporting quality in systematic reviews and meta-analyses in high-impact dental medicine journals between 1993-2018[J]. PLoS One, 2023, 18 (12): e0295864.
4 What is a reporting guideline[EB/OL]. [2026-03-01]. https://www.equator-network.org/about-us/what-is-a-reporting-guideline/.
5 陈耀龙. 医学研究报告规范的发展与简介[J]. 兰州大学学报(医学版), 2022, 48 (1): 1- 4.
6 雷斯媛, 李宣霖, 春柳, 等. 中医药领域研究报告规范特征分析[J]. 中国中西医结合杂志, 2021, 41 (9): 1061- 1067.
7 Li X Q , Tao K M , Zhou Q H , et al. Endorsement of the CONSORT statement by high-impact medical journals in China: A survey of instructions for authors and published papers[J]. PLoS One, 2012, 7 (2): e30683.
8 Song T J , Leng H F , Zhong L L , et al. CONSORT in China: Past development and future direction[J]. Trials, 2015, 16 (1): 243.
9 李娜, 李洁, 孙菲, 等. 我国医学期刊编辑对医学研究报告规范的认知度[J]. 中国科技期刊研究, 2019, 30 (4): 358- 363.
10 闫行敏, 杜娟, 刘天怡, 等. 医学研究报告规范在生物医学期刊中的采用情况及影响因素调查[J]. 中国全科医学, 2018, 21 (25): 3149- 3154.
11 中国科技期刊卓越行动计划二期入选项目公布[EB/OL]. (2024-11-28). [2026-03-01]. https://www.cast.org.cn/xkx/xs/tzgg/art/2024/art_312952280.html.
12 《中国循证医学》编辑部. CONSORT报告修订版: 提高平行随机对照试验报告质量的建议[J]. 中国循证医学, 2001 (3): 182- 184.
13 刘雪梅, 刘建平. 应用CONSORT提高医学期刊质量[J]. 编辑学报, 2002, 14 (3): 228- 229.
14 李幼平, 吴泰相, 李静, 等. 创建中国临床试验注册和发表机制的联合宣言[J]. 中国循证医学杂志, 2006, 6 (6): 393- 394.
15 吴泰相, 李幼平, 卞兆祥, 等. 实施临床试验报告规范, 提高临床试验透明度[J]. 中国循证医学杂志, 2007, 7 (8): 551- 554.
16 Chen Y , Yang K , Marušić A , et al. A reporting tool for practice guidelines in health care: The RIGHT statement[J]. Annals of Internal Medicine, 2017, 166 (2): 128- 132.
17 Cheng C W , Wu T X , Shang H C , et al. CONSORT extension for Chinese herbal medicine formulas 2017:Recommendations, explanation, and elaboration[J]. Annals of Internal Medicine, 2017, 167 (2): 112- 121.
18 郑颂华, 吴泰相, 商洪才, 等. 中药复方临床随机对照试验报告规范2017:CONSORT声明的扩展、说明与详述[J]. 中西医结合心脑血管病杂志, 2019, 17 (1): 1- 14.
19 Duan Y , Zhao L , Ma Y , et al. A cross-sectional study of the endorsement proportion of reporting guidelines in 1039 Chinese medical journals[J]. BMC Medical Research Methodology, 2023, 23 (1): 20.
20 邹强, 王琳辉, 张秀峰, 等. 中文生物医学期刊稿约的条目推荐(2024年版)[J]. 编辑学报, 2024, 36 (5): 501- 507.
21 Equator Network. Toolkits[EB/OL]. [2026-03-01]. https://www.equator-network.org/toolkits/.
22 David Moher, Douglas G. Altman, Kenneth F. Schulz, 等. 生物医学研究报告指南: 用户手册[M]. 陈耀龙, 张开平, 刘雷, 译. 长沙: 中南大学出版社, 2022.
23 李巍, 张薇. 中华医学会系列杂志稿约中临床试验注册规范的调查[J]. 中国科技期刊研究, 2019, 30 (9): 962- 966.
24 中华医学会杂志社指南与标准研究中心, 世界卫生组织指南实施与知识转化合作中心. 2020中华医学会系列杂志发表指南评价报告[J]. 中华医学杂志, 2021, 101 (24): 1839- 1847.
[1] 唐增煦,苑弘弢,许媛媛,崔云裳. 我国学术期刊在中国知网平台的增强出版现状和发展路径[J]. 科技与出版, 2026, 45(8): 75-88.
[2] 戴王娟,陈汐敏. 国际传播需求下中文医学期刊官网规范性建设研究—基于国内外综合性医学期刊的调查[J]. 科技与出版, 2026, 45(7): 95-109.
[3] 刘普,蔡英辉. 学术期刊在科研诚信建设中的职责定位与实践路径——基于近年来曝光的涉刊学术不端典型案例的分析[J]. 科技与出版, 2026, 45(6): 5-15.
[4] 彭秋归. 中华文明标识体系构建中学术期刊的作用及其提升研究[J]. 科技与出版, 2026, 45(5): 112-120.
[5] 王媛,王日臻,樊丽. 大语言模型在学术期刊中应用的风险防控与治理策略——基于内容原创性、学术诚信与数据安全的视角[J]. 科技与出版, 2026, 45(4): 119-128.
[6] 孙冠豪. 生成式人工智能赋能学术期刊出版的挑战与应对策略[J]. 科技与出版, 2026, 45(4): 59-68.
[7] 邬加佳,方引超,余菁,王景周. 医学期刊免除伦理审查论文标注的现状调查与分析[J]. 科技与出版, 2026, 45(4): 111-118.
[8] 赵文义,赵吉豫. 超越学术交流:学术期刊的媒介地理学分析[J]. 科技与出版, 2026, 45(4): 129-136.
[9] 沈锡宾,李鹏,黄丽洋,刘红霞,赵巍,吕相征,魏均民. 中国科技期刊集群加盟期刊协同发展与生态治理机制研究[J]. 科技与出版, 2026, 45(3): 93-104.
[10] 曾伟明,余佳佳. 构建“全球南方”学术数字出版平台  推动全球自主知识体系公平化[J]. 科技与出版, 2026, 45(2): 51-58.
[11] 李慧文,李玉乐,李娜,刘洋,杨爽. 基于RIGHT清单的中文医学科技核心期刊发表的专家共识质量评价[J]. 科技与出版, 2026, 45(2): 145-156.
[12] 刘普,孙婉婷. 社科学术期刊的AI使用政策图谱与治理进阶——基于50家社科学术期刊生成式人工智能使用政策文本的分析[J]. 科技与出版, 2025, 44(9): 52-62.
[13] 侯波,高虹. 高校学术期刊介导的学术不端四维协同治理机制研究——基于扎根理论的研究[J]. 科技与出版, 2025, 44(9): 107-116.
[14] 闫碧舟. 学术期刊补白的价值定位与实践策略[J]. 科技与出版, 2025, 44(8): 95-101.
[15] 刘娟,李建军. 文明互鉴背景下学术期刊讲好“一带一路”故事的多维分析——基于话语建构的审思[J]. 科技与出版, 2025, 44(7): 36-44.